Business Context and Reporting Period
This Form 8-K Current Report was filed by Pacific Biosciences of California, Inc. on April 2, 2012. The report addresses a specific corporate governance event rather than financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to Item 5.02 regarding personnel changes.
Material Changes
On April 2, 2012, Hugh Martin, a Class I director, resigned from the Board of Directors of Pacific Biosciences of California, Inc. The resignation was effective immediately and was attributed to personal reasons.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the immediate departure of the director.
Investor Verification Checklist
- Verify the effective date of Hugh Martin's resignation (April 2, 2012).
- Confirm the stated reason for departure (personal reasons).
- Check subsequent filings for the appointment of a replacement director to fill the Class I seat.